: Maybe a different shape or color to better distinguish pre vs post vaccination? Table 2 : Is it possible to have the Chinese symbols for the study names translated in English? Same thing for the references. For the non-Chinese speakers, this is impossible to identify and refer to these studies.
-Line 271: "the patterns appeared similar for all serogroups": you may want to specify here that it peaks during teenage years.
- Table 2 : -Sample size is missing but would be informative here -there is a typo in first line (Trotter et al) Grouping method - Table 4 : What are the weights associated with each question? Or is this ad-hoc from reference 10? In any case, clarifying would be welcome.
==================
Major comments ================== -Summary Figures 2,3,4 are great but a forest plot would be really welcome. It would help the readers making more sense of the pooled meta-analysis results you present.
-Especially for the Africa region, it would be helpful to identify the studies which took place in countries where an immunization program is offered and, if available, their estimated immunization coverage.
REVIEWER
Brian Greenwood London School of Hygiene and Tropical Medicine, London, UK.
REVIEW RETURNED
08-Jun-2018
GENERAL COMMENTS
The authors have conducted a detailed review of the prevalence of pharyngeal carriage with Neisseria meningitidis in relation to age, serogroup and geographical region focusing just on studies conducted since 2006. The inclusion of data from studies conducted in China, although some of these lack detail on how they were done, is a useful addition to the literature. I have a few comments and suggestions.
a. Purpose of the study. It would be helpful to mention in the introduction why the authors think that knowing the age distribution of carriage is important, for example is there evidence that such information has helped in determining vaccination strategies?
b.Scope of the study. Because of the changing pattern of meningococcal carriage over time there is logic to focussing on just recent studies but there are some lessons to be learnt from earlier studies, such as the relationship between carriage prevalence and epidemics and inclusion of the reference (Trotter and Greenwood LID 2007; 7:797) ,which covers some of these issues, could be useful.
c.Discussion. The authors highlight the difficulty in comparing results across studies because of the use of different diagnostic methods. It could be pointed out that this is likely to become an increasing problem unless concerted efforts are made to encourage a standardised method of measuring carriage, although it is not clear how this might be done. During the past decade there has been some progress in standardising methods on the way in which swabs are collected, and on the classical microbiological methods used to identify N. meningitidis, but the introduction of new approaches such as direct PCR on swabs is likely to increase difficult in comparing results across studies and in conducting any kind of useful meta-analysis in the future. this could be mentioned. An additional point not highlighted in the discussion in the rapidity with which the carriage situation can change -for example very different findings can be found one year after an initial survey. 

General Comments
The article provides a comprehensive review of the available data on meningococcal carriage including data from all regions of the world which is relatively unique as previously most review articles have focused on Europe, North and South America. The manuscript is well written, referenced appropriately and clearly meets the Prisma criteria as described in the provided tables. However, there is one major issue with the manuscript that needs to be addressed. The objective of the study is clearly stated as: "…to characterize serogroup-specific meningococcal carriage by age group and world region from 2006-2017". The data described in the manuscript focus only on large age groupings, mainly for adolescents and young adults for Europe and the Americas, while only data from Africa provides a wide age range. There are no clear conclusions from the analysis on the topic of variation of serogroup distribution within carriage prevalence by age, as a confounding bias of region prevents this in the current analysis. Within region, only the data from Africa seems to allow an analysis by age whereas the European data only allows an analysis of adolescents versus young adults. It is not clear if this division of the data is driven by data availability (presumably) or was selected by the authors. The manuscript would benefit from a more defined review and conclusions on the data available with further description on the limitations of the aggregated data. Overall this paper is clearly written and the statistical methods are sound. I just have a couple of major (less minor) points that I think should be addressed.
Thank you for your comments. We have addressed each one in turn below.
================== Minor comments ==================
Line 150: please, as customary, give the reference for the software and its version. We have added the reference for the statistical package used (line 196).
Line 159-162: The data from the least sensitive methods were then ignored? I don't see what proportion of data is being discarded in the tables or supplement. I think it's worth disclosing it.
When studies reported the results of more than one method, we reported the results in Supplemental Table 2 . We have included a notation in the table for which results we included in the analysis and cited the table for clarity (Supplemental Table 2 and lines 205-207).
Line 166: how the vaccination coverage was evaluated?
We utilized cohort or national vaccination coverage reported by the study authors. We have added additional details to the methods section for clarity (lines 217-219).
Line 168: I don't think it's a good reason. You could envisage indirect vaccine effect in the _same_ age group. But I'm not sure how feasible and how much more work this implies. (it sounds more like another paper could address that...)
We have removed the phrase. As mentioned, it is outwith the scope of this paper to consider indirect effects in the analysis (line 219). Figure 2&4 : Maybe a different shape or color to better distinguish pre vs post vaccination?
We have changed the color of the pre-vaccination estimates to more clearly distinguish them (Figures 2 and 4). Table 2 : Is it possible to have the Chinese symbols for the study names translated in English? Same thing for the references. For the non-Chinese speakers, this is impossible to identify and refer to these studies.
We have translated all Chinese citations including author, title, and journal names.
We have added the specification as suggested (line 342).
- Table 2 : -Sample size is missing but would be informative here
We have added sample size to this table (now Supplemental Table 3 ).
-there is a typo in first line (Trotter et al) Grouping method
We have corrected the typo.
- Table 4 : What are the weights associated with each question? Or is this ad-hoc from reference 10? In any case, clarifying would be welcome.
The listed questions do come from reference 10. The bolded questions are from the risk of bias assessment and the non-bolded explanations further detail how we used the assessment for our specific review. Each question was weighted equally. We included a The authors have conducted a detailed review of the prevalence of pharyngeal carriage with Neisseria meningitidis in relation to age, serogroup and geographical region focusing just on studies conducted since 2006. The inclusion of data from studies conducted in China, although some of these lack detail on how they were done, is a useful addition to the literature. I have a few comments and suggestions.
Many thanks for your comments and suggestions. We have addressed each in turn below.
We have added additional details concerning the rationale in the introduction (lines 139-141).
We have added a relevant discussion point (lines 355-357).
c.Discussion. The authors highlight the difficulty in comparing results across studies because of the use of different diagnostic methods. It could be pointed out that this is likely to become an increasing problem unless concerted efforts are made to encourage a standardised method of measuring carriage, although it is not clear how this might be done. During the past decade there has been some progress in standardising methods on the way in which swabs are collected, and on the classical microbiological methods used to identify N. meningitidis, but the introduction of new approaches such as direct PCR on swabs is likely to increase difficult in comparing results across studies and in conducting any kind of useful meta-analysis in the future. this could be mentioned. An additional point not highlighted in the discussion in the rapidity with which the carriage situation can change -for example very different findings can be found one year after an initial survey.
We have added additional discussion points on these topics (lines 424-428 and lines 438-442).
d. Figures and Tables. Currently there are 3 figures and 6 tables in the paper. Consideration could be given to moving some of the tables, perhaps 4-6, to a supplement .
We included Figures 1, 2, 3 , and 4 in the main text and the remaining figures and tables are included in the supplemental materials.
e.References. There are two sets of references, the second covering material presented in the tables. These needed be consolidated unless there is a supplement for which a second list of references is needed.
We have ensured that only one set of references are included in each the main text and the supplemental material.
f. Minor points. -L.202 -2004 . The statement that most African studies did not specify age group is ambiguous. Some did break down findings in different age groups although there were usually insufficient capsulated isolates to do this by serogroup We have altered to figure for clarity by changing the color of the pre-vaccination estimates to more clearly stand out. The pre-and post-designations are also indicated in the labels in the figure.
- Fig 2 . Other groups. It is not clear if this relates to other capsulated isolates, non-capsulated isolates or both.
We have included more information in the figure label for clarity to notate that it refers to both noncapsulated and other capsulated isolates.
- Table 4 . No studies are given a red ranking so this can be removed from the legend.
We have removed the red ranking from the Table 4 
General Comments
The article provides a comprehensive review of the available data on meningococcal carriage including data from all regions of the world which is relatively unique as previously most review articles have focused on Europe, North and South America. The manuscript is well written, referenced appropriately and clearly meets the Prisma criteria as described in the provided tables.
Thank you for your comments. We have addressed each in turn below.
However, there is one major issue with the manuscript that needs to be addressed. The objective of the study is clearly stated as: "…to characterize serogroup-specific meningococcal carriage by age group and world region from 2006-2017". The data described in the manuscript focus only on large age groupings, mainly for adolescents and young adults for Europe and the Americas, while only data from Africa provides a wide age range. There are no clear conclusions from the analysis on the topic of variation of serogroup distribution within carriage prevalence by age, as a confounding bias of region prevents this in the current analysis. Within region, only the data from Africa seems to allow an analysis by age whereas the European data only allows an analysis of adolescents versus young adults. It is not clear if this division of the data is driven by data availability (presumably) or was selected by the authors. The manuscript would benefit from a more defined review and conclusions on the data available with further description on the limitations of the aggregated data.
We have further clarified that restricting the meta-analysis to the reported age groups was driven by available data (line 67 and lines 295-298). We have reworded the conclusions (lines 78-80 and lines 447-449).
Specific comments: 1. P2, L61-63: Conclusion needs to be made more clear. In fact there are data gaps across all regions except Africa and what can truly be stated about the influence of age. The results suggest that there were differences of prevalence and serogroup distribution although these seem only to be trends.
We have reworded the conclusions for clarity (lines 78-80 and lines 447-449).
2.
P2, L71-72: Ensure it is clear why the age groups were selected We have reworded the sentence for clarity (line 67) and added an additional sentence to the methods section (lines 190-191) .
3.
P4, L163-165: The rationale for the analysis described is unclear. There was only a small number of studies included that were post-vaccination and the impact of vaccine is dependent upon many factors beyond just availability of vaccine (age group targeted, implementation, duration since vaccine implementation)
We included this subgroup analysis in order to account for the direct effect of vaccination on carriage prevalence among included cohorts. We used reported data indicating whether a substantial amount of participants (defined as ≥25% of each study's cohort) was vaccinated or not against a certain capsular group. It was outwith the scope of this review and analysis to consider indirect effects. We have reworded the sentences for clarity (lines 217-218).
4.
P5 L188-195: What was the criteria for selecting the most sensitive data? There were many variables included in the studies and it would be good for the authors to expand on how they came to this decision
We have reworded this section for clarity (lines 205-207) and included notations in Supplemental Table 2 to indicate which results were included in the review.
5.
P6 L22: It is unclear if the authors are referring to a carriage study or the recent increase of serogroup W disease in England.
We have reworded the sentence for clarity (lines 283).
P6 L244: Please define post-vaccination
We have reworded the sentence for clarity (lines 217-218).
7. P7 L293-294: The statement is incorrect has high carriage of any serogroup does not translate into high rates of disease. The best example of this is serogroup Y which is actually responsible for small number of cases yet the carriage rate tends to be relatively high in carriage studies.
We have reworded the sentence for clarity (lines 369-370).
8.
P8 L336-338: The reason why there is a reference to MATS here is unclear. This assay is not designed to inform on vaccine antigen expression from carriage strains, it has only been validated for disease isolates.
We have removed this reference (lines 415).
9.
P9 L362 Conclusion -please see comments above re conclusions that can be made from the study.
We have reworded the conclusions for clarity as mentioned above.
VERSION 2 -REVIEW
REVIEWER
David Champredon York University, Canada REVIEW RETURNED 16-Oct-2018
GENERAL COMMENTS
All my comments were addressed.
REVIEWER
Brian Greenwood London School of Hygiene and Tropical Medicine REVIEW RETURNED
27-Oct-2018
GENERAL COMMENTS
The authors have conducted a detailed and careful study of recent, published meningococcal carriage studies with the aim of determining whether the age distribution of carriers is influenced by serogroup. Unfortunately, it has not been possible to come to any definitive conclusion because of the paucity of information on the prevalence of carriage over the full age range outside the meningitis belt of Africa.
I have no comments on the methodology of the review which used appropriate sampling and statistical methods and which has been carefully done. A large number of tables and figures are presented in the supplement that may be useful to others interested in this topic, for example those showing comparisons between results using different collection, and analytical methods.
My main comments relate to the discussion and includea. The heterogeneity in carriage prevalence over time and place. The review illustrates once again the remarkable heterogeneity between the results of different studies with carriages rates varying from 0 to 70%. Some of this may be due to methodological differences, as noted in the discussion, and more efforts are needed to try to make these more standardised, but recent studies in the African meningitis belt which used standardised methods showed major differences in carriage rates and serogroup distribution between places geographically close to each other and over time in the same place with the carriage rate varying dramatically over a period of months. Factors causing these changes are likely to include introduction of a new strain, an increase in risk factors such an outbreak of a viral infection etc. and all of these factors may influence the age distribution of carriers. For example introduction of a new strain to which the population has little immunity is likely to lead to carriage in a wider age range of the population as opposed to the situation in which a strain has been circulating for some time in the community inducing immunity in older subjects. A respiratory infection, an important risk factor, might affect primarily young children. For reasons such as this it would not be surprising if no consistent relationship between carriage prevalence and age could be found and this point could be given more attention in the discussion.
b. Method of analysis. It is possible that the method of detection could influence the age pattern of carriage, for example low density infections detected only by a sensitive PCR could have a different age distribution from those detected by less sensitive conventional microbiological technique with older subjects being expected to have more low density infections, adding further difficulty in making comparisons between studies which have sued different methods and this could be mentioned in the discussion.
c. Vaccination. Vaccination with conjugate vaccines has a marked impact on carriage. Although there is evidence of a herd effect it would be anticipated that vaccination of only a selected age group of the population would have major impact on the age distribution of carriage in the population as a whole and it is not clear how this was handled in the review. Overall carriage rates in the population may not be reflect the situation in the population studied in the carriage survey.
REVIEWER
Paul Balmer
Pfizer Vaccines, United States REVIEW RETURNED 24-Oct-2018
GENERAL COMMENTS
The data and subsequent analyses regarding pre and post vaccination remains an issue. It is not possible for the reader to easily track which references are being used for this analyses. It still seems that the analysis of any vaccine impact is beyond the remit of the paper and no formal analyses should be performed. Impact of vaccine depends upon many factors and this has not been addressed. The addition of the substantial number of forest plots, while a significant piece of work, does not really add to the manuscript. It seems that the reviewer who requested this was really looking for a forest plot summarizing the data, rather than one for each individual variable (country, region, age etc). The authors have conducted a detailed and careful study of recent, published meningococcal carriage studies with the aim of determining whether the age distribution of carriers is influenced by serogroup. Unfortunately, it has not been possible to come to any definitive conclusion because of the paucity of information on the prevalence of carriage over the full age range outside the meningitis belt of Africa.
VERSION 2 -AUTHOR RESPONSE
My main comments relate to the discussion and includea. The heterogeneity in carriage prevalence over time and place. The review illustrates once again the remarkable heterogeneity between the results of different studies with carriages rates varying from 0 to 70%. Some of this may be due to methodological differences, as noted in the discussion, and more efforts are needed to try to make these more standardised, but recent studies in the African meningitis belt which used standardised methods showed major differences in carriage rates and serogroup distribution between places geographically close to each other and over time in the same place with the carriage rate varying dramatically over a period of months. Factors causing these changes are likely to include introduction of a new strain, an increase in risk factors such an outbreak of a viral infection etc. and all of these factors may influence the age distribution of carriers. For example introduction of a new strain to which the population has little immunity is likely to lead to carriage in a wider age range of the population as opposed to the situation in which a strain has been circulating for some time in the community inducing immunity in older subjects. A respiratory infection, an important risk factor, might affect primarily young children. For reasons such as this it would not be surprising if no consistent relationship between carriage prevalence and age could be found and this point could be given more attention in the discussion. We have added additional discussion points on this matter (lines 426-432 in the marked copy).
We have added additional discussion points on this matter (lines 409-412 in the marked copy).
c. Vaccination. Vaccination with conjugate vaccines has a marked impact on carriage. Although there is evidence of a herd effect it would be anticipated that vaccination of only a selected age group of the population would have major impact on the age distribution of carriage in the population as a whole and it is not clear how this was handled in the review. Overall carriage rates in the population may not be reflect the situation in the population studied in the carriage survey. Thorough investigation into vaccination effects are beyond the scope of this review. We have added an additional limitation point on this matter (lines 446-448 in the marked copy). The data and subsequent analyses regarding pre and post vaccination remains an issue. It is not possible for the reader to easily track which references are being used for this analyses. It still seems that the analysis of any vaccine impact is beyond the remit of the paper and no formal analyses should be performed. Impact of vaccine depends upon many factors and this has not been addressed. We agree on the limitations mentioned and have removed these analyses from the manuscript, Figures 2 and 4 , and Supplemental Table 6 ). We have added to the discussion of limitations concerning not considering vaccine use in the analysis (lines 446-448 in the marked copy).
The addition of the substantial number of forest plots, while a significant piece of work, does not really add to the manuscript. It seems that the reviewer who requested this was really looking for a forest plot summarizing the data, rather than one for each individual variable (country, region, age etc). Since each analysis was run independently, the forest plots reported are the ones summarizing the data. Due to the substantial number of forest plots, we created the summary figure that is reported in the main document. We have removed the forest plots from the supplemental material but have them on file in case future readers inquire about specific analyses. 
GENERAL COMMENTS
The authors have addressed all my comments
